2025-521357-17-00招募中1 期
To investigate the safety and efficacy of a novel investigational compound against neurological diseases such as Parkinson's disease in healthy men and women and patients with Parkinson's disease.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 68
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Philip Kremer
Scientific
Teitur Trophics ApS
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
不适用
A study to determine the safety and efficacy of a terbinafine topical formulation system in subjects with onychomycosis in laser treated toenails versus ciclopirox lacquer in intact toenailsDistal/lateral Subungual onychomycosis (DSO) caused by dermatophytesMedDRA version: 8.1Level: LLTClassification code 10030338Term: OnychomycosisEUCTR2006-005895-42-ISTLT Medical Ltd.235
已完成
不适用
Investigation about safety and utility of the new minimally invasive needle .JPRN-UMIN000013005Yokohama City University Hospital4
已完成
Unknown
study on overall improvement of Skin ParametersCTRI/2023/06/054242Transformative Learning Solutions Pvt Ltd75
招募中
3 期
A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Docetaxel Versus Placebo + Docetaxel as Treatment for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)Metastatic Castration Resistant Prostate CancerJPRN-jRCT2031220214Hibi Kazushige80
进行中（未招募）
1 期
A Study to Evaluate the Safety and efficacy of the Antibody APX005M in Adult Patients with Metastatic Melanoma Who have not Received Prior Immunotherapynresectable or metastatic melanomaMedDRA version: 20.0 Level: LLT Classification code 10027481 Term: Metastatic melanoma System Organ Class: 100000004864EUCTR2018-003864-30-ESApexigen, Inc.36